Search Results - "HESS, J. Fred"
-
1
Inhibition of O-GlcNAcase leads to elevation of O-GlcNAc tau and reduction of tauopathy and cerebrospinal fluid tau in rTg4510 mice
Published in Molecular neurodegeneration (18-05-2017)“…Hyperphosphorylation of microtubule-associated protein tau is a distinct feature of neurofibrillary tangles (NFTs) that are the hallmark of neurodegenerative…”
Get full text
Journal Article -
2
Discovery of MK-8719, a Potent O‑GlcNAcase Inhibitor as a Potential Treatment for Tauopathies
Published in Journal of medicinal chemistry (27-11-2019)“…Inhibition of O-GlcNAcase (OGA) has emerged as a promising therapeutic approach to treat tau pathology in neurodegenerative diseases such as Alzheimer’s…”
Get full text
Journal Article -
3
Early intervention of tau pathology prevents behavioral changes in the rTg4510 mouse model of tauopathy
Published in PloS one (06-04-2018)“…Although tau pathology, behavioral deficits, and neuronal loss are observed in patients with tauopathies, the relationship between these endpoints has not been…”
Get full text
Journal Article -
4
Analysis of tau post-translational modifications in rTg4510 mice, a model of tau pathology
Published in Molecular neurodegeneration (26-03-2015)“…Microtubule associated protein tau is the major component of the neurofibrillary tangles (NFTs) found in the brains of patients with Alzheimer's disease and…”
Get full text
Journal Article -
5
Decreased BMD and Limb Deformities in Mice Carrying Mutations in Both Lrp5 and Lrp6
Published in Journal of bone and mineral research (01-12-2004)“…Humans and mice lacking Lrp5 have low BMD. To evaluate whether Lrp5 and Lrp6 interact genetically to control bone or skeletal development, we created mice…”
Get full text
Journal Article -
6
Allosteric Modulation of Group III Metabotropic Glutamate Receptor 4: A Potential Approach to Parkinson's Disease Treatment
Published in Proceedings of the National Academy of Sciences - PNAS (11-11-2003)“…Parkinson's disease (PD) is a debilitating movement disorder that afflicts >1 million people in North America. Current treatments focused on…”
Get full text
Journal Article -
7
Attenuation of scratch‐induced reactive astrogliosis by novel EphA4 kinase inhibitors
Published in Journal of neurochemistry (01-09-2011)“…J. Neurochem. (2011) 118, 1016–1031. The EphA4 receptor and its ephrin ligands are involved in astrocytic gliosis following CNS injury. Therefore, a strategy…”
Get full text
Journal Article -
8
Genome-Wide Microarray Analysis of the Differential Neuroprotective Effects of Antioxidants in Neuroblastoma Cells Overexpressing the Familial Parkinson’s Disease α-Synuclein A53T Mutation
Published in Neurochemical research (2010)“…In Parkinson’s disease substantia nigra neurons degenerate likely due to oxidative damage interacting with genetic risk factors. Here, SH-SY5Y cells expressing…”
Get full text
Journal Article -
9
Disruption of the Keap1-containing ubiquitination complex as an antioxidant therapy
Published in Current topics in medicinal chemistry (01-05-2007)“…The transcription of antioxidant response element (ARE)-containing cytoprotective genes has been proposed as a means to combat oxidative stress-related…”
Get more information
Journal Article -
10
-
11
Discovery of 6‑(Fluoro-18 F)‑3-(1H‑pyrrolo[2,3‑c]pyridin-1-yl)isoquinolin-5-amine ([18F]-MK-6240): A Positron Emission Tomography (PET) Imaging Agent for Quantification of Neurofibrillary Tangles (NFTs)
Published in Journal of medicinal chemistry (26-05-2016)“…Neurofibrillary tangles (NFTs) made up of aggregated tau protein have been identified as the pathologic hallmark of several neurodegenerative diseases…”
Get full text
Journal Article -
12
The effects of deleting the mouse neurotensin receptor NTR1 on central and peripheral responses to neurotensin
Published in The Journal of pharmacology and experimental therapeutics (01-01-2002)“…Mice deficient in the neurotensin (NT)-1 receptor (NTR1) were developed to characterize the NT receptor subtypes that mediate various in vivo responses to NT…”
Get more information
Journal Article -
13
The NOD Idd9 Genetic Interval Influences the Pathogenicity of Insulitis and Contains Molecular Variants of Cd30, Tnfr2, and Cd137
Published in Immunity (Cambridge, Mass.) (01-07-2000)“…Previous analyses of NOD mice have shown that some genes control the development of both insulitis and diabetes, while other loci influence diabetes without…”
Get full text
Journal Article -
14
Discovery of a Potent, Non-peptide Bradykinin B1 Receptor Antagonist
Published in Journal of the American Chemical Society (25-06-2003)“…Bradykinin (BK) plays an important role in the pathophysiological processes accompanying pain and inflammation. Selective bradykinin B1 receptor antagonists…”
Get full text
Journal Article -
15
Haplotype structure, LD blocks, and uneven recombination within the LRP5 gene
Published in Genome research (01-05-2003)“…Patterns of linkage disequilibrium (LD) in the human genome are beginning to be characterized, with a paucity of haplotype diversity in "LD blocks,"…”
Get full text
Journal Article -
16
Generation and characterization of a human bradykinin receptor B1 transgenic rat as a pharmacodynamic model
Published in The Journal of pharmacology and experimental therapeutics (01-08-2004)“…Antagonists of the B1 bradykinin receptor (B1R) offer the promise of novel therapeutic agents for the treatment of inflammatory and neuropathic pain. However,…”
Get more information
Journal Article -
17
Conserved Aspartate Residues and Phosphorylation in Signal Transduction by the Chemotaxis Protein CheY
Published in Proceedings of the National Academy of Sciences - PNAS (01-01-1990)“…The CheY protein is phosphorylated by CheA and dephosphorylated by CheZ as part of the chemotactic signal transduction pathway in Escherichia coli…”
Get full text
Journal Article -
18
Leptin receptor missense mutation in the fatty Zucker rat
Published in Nature genetics (01-05-1996)“…The discovery of leptin, a peptide hormone synthesized in adipocytes, has led to the identification of a novel signal transduction pathway involved in the…”
Get full text
Journal Article -
19
Development of Orally Bioavailable and CNS Penetrant Biphenylaminocyclopropane Carboxamide Bradykinin B1 Receptor Antagonists
Published in Journal of medicinal chemistry (25-01-2007)“…A series of biphenylaminocyclopropane carboxamide based bradykinin B1 receptor antagonists has been developed that possesses good pharmacokinetic properties…”
Get full text
Journal Article -
20
Increased nuclear factor‐erythroid 2 p45‐related factor 2 activity protects SH‐SY5Y cells against oxidative damage
Published in Journal of neurochemistry (01-10-2005)“…The ability of cells to control the balance between the generation and quenching of reactive oxygen species is important in combating potentially damaging…”
Get full text
Journal Article